ID   KthES11
AC   CVCL_UM06
SY   KUIMSe004-A
DR   hPSCreg; KUIMSe004-A
DR   Wikidata; Q95980472
RX   PubMed=33059130;
RX   PubMed=33225099;
RX   PubMed=34126558;
WW   Info; Kyoto University; -; http://www2.infront.kyoto-u.ac.jp/es01/KthES11.htm
CC   Group: Clinical grade pluripotent cell line.
CC   From: Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
RX   PubMed=33059130; DOI=10.1016/j.scr.2020.102020;
RA   Kawase E., Takada K., Suemori H.;
RT   "Kyoto hESC cell resource for regenerative medicine.";
RL   Stem Cell Res. 49:102020-102020(2020).
//
RX   PubMed=33225099; DOI=10.31662/jmaj.2018-0029; PMCID=PMC7676987;
RA   Umezawa A., Sato Y., Kusakawa S., Amagase R., Akutsu H., Nakamura K.,
RA   Kasahara M., Matsubara Y., Igarashi T.;
RT   "Research and development strategy for future embryonic stem
RT   cell-based therapy in Japan.";
RL   JMA J. 3:287-294(2020).
//
RX   PubMed=34126558; DOI=10.1016/j.scr.2021.102383;
RA   Kawase E., Takada K., Nakatani R., Yamazaki S., Suemori H.;
RT   "Generation of clinical-grade human embryonic stem cell line KthES11
RT   according to Japanese regulations.";
RL   Stem Cell Res. 54:102383-102383(2021).
//